![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
AN INTEGRATED ANALYSIS OF 402 COMPENSATED CIRRHOTIC PATIENTS WITH HCV GENOTYPE (GT) 1, 4 or 6 INFECTION TREATED WITH Elbasvir/GRAZOPREVIR
|
|
|
Reported by Jules Levin
AASLD Nov 13-17 San Francisco, CA
Ira Jacobson, Eric Lawitz, Paul Kwo,
Christophe Hezode, Cheng-Yuan Peng,
Anita Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber
![AASLD1.gif](../images/111915/111915-1/AASLD1.gif)
![AASLD2.gif](../images/111915/111915-1/AASLD2.gif)
![AASLD3.gif](../images/111915/111915-1/AASLD3.gif)
![AASLD4.gif](../images/111915/111915-1/AASLD4.gif)
![AASLD5.gif](../images/111915/111915-1/AASLD5.gif)
![AASLD6.gif](../images/111915/111915-1/AASLD6.gif)
![AASLD7.gif](../images/111915/111915-1/AASLD7.gif)
![AASLD8.gif](../images/111915/111915-1/AASLD8.gif)
![AASLD9.gif](../images/111915/111915-1/AASLD9.gif)
![AASLD10.gif](../images/111915/111915-1/AASLD10.gif)
![AASLD11.gif](../images/111915/111915-1/AASLD11.gif)
![AASLD12.gif](../images/111915/111915-1/AASLD12.gif)
![AASLD13.gif](../images/111915/111915-1/AASLD13.gif)
![AASLD14.gif](../images/111915/111915-1/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|